Ishita Drugs Shows Mixed Financial Performance Amid Shift in Market Sentiment

Oct 10 2025 08:07 AM IST
share
Share Via
Ishita Drugs & Industries has recently adjusted its technical outlook, shifting from bearish to mildly bearish. The company reported a 32.27% increase in net sales for the latest quarter, achieving its highest quarterly profit after tax. However, long-term fundamentals show some weaknesses, including a modest return on equity.
Ishita Drugs & Industries has recently undergone an adjustment in evaluation, reflecting a shift in its technical outlook. The stock's technical trend has transitioned from bearish to mildly bearish, indicating a nuanced change in market sentiment.

Key financial metrics reveal that Ishita Drugs has experienced a positive performance in its latest quarter, with net sales reaching Rs 9.96 crore, marking a growth of 32.27%. Additionally, the company reported its highest quarterly profit after tax (PAT) at Rs 0.30 crore and a peak in profit before depreciation, interest, and taxes (PBDIT) at Rs 0.35 crore. Despite these positive indicators, the company's long-term fundamentals show some weaknesses, including an average return on equity (ROE) of 8.40% and a modest annual growth rate in net sales of 5.54% over the past five years.

The stock has generated a return of -6.10% over the last year, underperforming against broader market indices. However, it is trading at a discount compared to its peers' average historical valuations, with a price-to-book value of 2.1.

For more insights on Ishita Drugs & Industries and its financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News